180 related articles for article (PubMed ID: 19878212)
1. 4-Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes.
Xu TY; Chen RH; Wang P; Zhang RY; Ke SF; Miao CY
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):441-6. PubMed ID: 19878212
[TBL] [Abstract][Full Text] [Related]
2. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
[TBL] [Abstract][Full Text] [Related]
3. (-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus.
Freund P; Wolff HP; Kühnle HF
Metabolism; 1995 May; 44(5):570-6. PubMed ID: 7752903
[TBL] [Abstract][Full Text] [Related]
4. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
[TBL] [Abstract][Full Text] [Related]
5. Antihyperglycemic action of guanidinoalkanoic acids: 3-guanidinopropionic acid ameliorates hyperglycemia in diabetic KKAy and C57BL6Job/ob mice and increases glucose disappearance in rhesus monkeys.
Meglasson MD; Wilson JM; Yu JH; Robinson DD; Wyse BM; de Souza CJ
J Pharmacol Exp Ther; 1993 Sep; 266(3):1454-62. PubMed ID: 8371149
[TBL] [Abstract][Full Text] [Related]
6. [D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice.
Grasso P; Rozhavskaya-Arena M; Leinung MC; Lee DW
Regul Pept; 2001 Sep; 101(1-3):123-9. PubMed ID: 11495687
[TBL] [Abstract][Full Text] [Related]
7. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes.
Ozcan U; Yilmaz E; Ozcan L; Furuhashi M; Vaillancourt E; Smith RO; Görgün CZ; Hotamisligil GS
Science; 2006 Aug; 313(5790):1137-40. PubMed ID: 16931765
[TBL] [Abstract][Full Text] [Related]
8.
Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
[No Abstract] [Full Text] [Related]
9. TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models.
Tsumura Y; Tsushima Y; Tamura A; Hasebe M; Kanou M; Kato H; Kobayashi T
PLoS One; 2017; 12(2):e0172252. PubMed ID: 28207836
[TBL] [Abstract][Full Text] [Related]
10. 4-Phenylbutyrate (PBA) treatment reduces hyperglycemia and islet amyloid in a mouse model of type 2 diabetes and obesity.
de Pablo S; Rodríguez-Comas J; Díaz-Catalán D; Alcarraz-Vizán G; Castaño C; Moreno-Vedia J; Montane J; Parrizas M; Servitja JM; Novials A
Sci Rep; 2021 Jun; 11(1):11878. PubMed ID: 34088954
[TBL] [Abstract][Full Text] [Related]
11. Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis.
Asensio C; Cettour-Rose P; Theander-Carrillo C; Rohner-Jeanrenaud F; Muzzin P
Endocrinology; 2004 May; 145(5):2206-13. PubMed ID: 14962997
[TBL] [Abstract][Full Text] [Related]
12. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
Sreejayan N; Dong F; Kandadi MR; Yang X; Ren J
Obesity (Silver Spring); 2008 Jun; 16(6):1331-7. PubMed ID: 18388893
[TBL] [Abstract][Full Text] [Related]
13. Effects of CP-900691, a novel peroxisome proliferator-activated receptor α, agonist on diabetic nephropathy in the BTBR ob/ob mouse.
Askari B; Wietecha T; Hudkins KL; Fox EJ; O'Brien KD; Kim J; Nguyen TQ; Alpers CE
Lab Invest; 2014 Aug; 94(8):851-62. PubMed ID: 24955894
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
[TBL] [Abstract][Full Text] [Related]
15. Asiatic acid mitigates hyperglycemia and reduces islet fibrosis in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.
Wang X; Lu Q; Yu DS; Chen YP; Shang J; Zhang LY; Sun HB; Liu J
Chin J Nat Med; 2015 Jul; 13(7):529-34. PubMed ID: 26233843
[TBL] [Abstract][Full Text] [Related]
16. Anti-Diabetic Effect of Organo-Chalcogen (Sulfur and Selenium) Zinc Complexes with Hydroxy-Pyrone Derivatives on Leptin-Deficient Type 2 Diabetes Model ob/ob Mice.
Nishiguchi T; Yoshikawa Y; Yasui H
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29215553
[TBL] [Abstract][Full Text] [Related]
17. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
Young AA; Gedulin BR; Bhavsar S; Bodkin N; Jodka C; Hansen B; Denaro M
Diabetes; 1999 May; 48(5):1026-34. PubMed ID: 10331407
[TBL] [Abstract][Full Text] [Related]
18. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
19. Repeated electroconvulsive shock normalizes blood glucose levels in genetically obese mice (C57BL/6J ob/ob) but not in genetically diabetic mice (C57BL/KsJ db/db).
Nutt DJ; Gleiter CH; Linnoila M
Brain Res; 1988 May; 448(2):377-80. PubMed ID: 3378162
[TBL] [Abstract][Full Text] [Related]
20. Decreased blood glucose excursion by nateglinide ameliorated neuropathic changes in Goto-Kakizaki rats, an animal model of non-obese type 2 diabetes.
Kitahara Y; Miura K; Takesue K; Mine T; Wada R; Uchida Y; Ito S; Yagihashi S
Metabolism; 2002 Nov; 51(11):1452-7. PubMed ID: 12404197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
